Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients

MedGenMed Medscape General Medicine

Volumn 6, Issue 3, 2004, Pages

  Asfour, M ^a   Narvios, Aida ^b   Lichtiger, Benjamin ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; RHESUS D ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNIZATION; APHERESIS; BLOOD COMPATIBILITY; BLOOD COMPONENT THERAPY; BLOOD DONOR; BLOOD TRANSFUSION; CELL MATURATION; ERYTHROCYTE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; MYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION;

EID: 25144512480     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Gunson HH, Stratton F, Phillip PK. The use of modified cells to induce an anti-Rh response. Br J Haematol. 1971;21:683-694.
2. Cook K, Rush B. D immunization after massive transfusion of D-positive blood. Med J Aust. 1974;1:166-168.
3. Coles SM, Klein HG, Holland PV. Alloimmunization in two multitransfused patient populations. Transfusion. 1981;21:462-466.
4. Seyfried H, Walewska I. Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Mater Med Pol. 1990;22:21-25.
5. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusions. Transfusion. 1990;30:532-535.
6. Monlar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D-pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion. 2002;42:177-182.
7. Quijada JG. Post transfusion alloimmunization (letter). Br J Haematol. 1996;95:573-574.
8. Walker RH, Lin DT, Hartrick MB. Alloimmunization following blood transfusion. Arch Pathol Lab Med. 1989;113:254-261.
9. Esteve J, Alcorta I, Pereria A, et al. Anti-D antibody of exclusive IgM class after minor Rh (D)-mismatched MBT (letter). Bone Marrow Transplantation. 1995;16:632-633.
10. Mohandas K, Aledort L. Transfusion requirements, risks, and costs for patients with malignancy. Transfusion. 1995;35:427-430.
11. Schonewille H, Haak Hl, Zijl AM. Alloimmunisation after blood transfusion in patients with hematological and oncological diseases. Transfusion. 1999;39:763-771.
12. Boctor F, Ali N, Mohandas K, Uehlinger J. Absence of D-alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion. 2003;43:173-176.
13. Ramsey G, Hahn LF, Cornell FW, et al. Low rate of rhesus immunization from Rh-incompatible blood transfusion during liver and heart transplant surgery. Transplantation. 1989;47:993-995.
14. Casanueva M, Valdes MD, Ribera MC. Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion. 1994;34:570-572.
15. Goldfinger D, McGinnis MH. Rh-incompatible platelet transfusion-risk and consequences of sensitizing immunosuppressed patients. N Engl J Med. 1971;284:942-944.
16. Mijovic A. Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning. Vox Sang. 2002;83:358-362.
17. Dutcher JP, Schiffer CA, Aisner J, et al. Long-term follow-up of patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized. Blood. 1981;58:1007-1011.
18. Zeiler Th, Wittmann G, Zingsem J, et al. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunization after RhD-incompatible single donor platelet transfusion (letter). Vox Sang. 1994;66:243.
19. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999;39:763-771.
20. Barrett AJ. Non-myeloablative stem cell transplants. Br J Haematol. 2000;111:6-17.
21. Lichtiger B, Hester JP. Transfusion of Rh-incompatible blood components to cancer patients. Hematologica (Budap). 1986;19:18-19.
22. Lichtiger B, Surgeon J, Rhorer S. Rh-incompatble platelet transfusion therapy in cancer patients: a study of 30 cases. Vox Sang. 1983;45:139-143.
23. De la Rubia J, Garcia R, Arriaga F, Guinot M, Lopez F, Marty ML. Anti-D immunization after transfusion of 4 units of fresh frozen plasma. Vox Sang. 1994;66:297-298.
24. Wernet D, Weiss B, Schmidt H, et al. Antigen-independent reactivation of anti-E, years after allogeneic bone marrow transplantation: a case report. Br J Haematol. 1999;91:758-760.
25. Baldwin ML, Ness PM, Scott D, et al. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion. 1988;28:330-333.
26. Gandini G. Detection of an anti-RhD antibody 2 years after sensitization in a patient who had undergone an allogeneic BMT. Bone Marrow Transplantation. 2000;25:457-459.
27. Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusion: risks and consequences of sensitizing immunosuppressed patients. N Engl J Med. 1971;284:942-944.
28. Cid J, Ortin X, Elies E, et al. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion. 2002;42:173-176.
29. Molnar R, Johnson R, Sweat LT, Geiger TL. Absence of D alloimmunization in D negative pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion. 2002;42:177-182.
30. Holohan TV, Terasaki PI, Deisseroth AB. Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood. 1981;58:122-128.
31. McLeod BC, Piehl MR, Sassetti RJ. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients. Vox Sang. 1990;59:185-189.
32. Abou Elella AA, Camarillo TA, Allen MB, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion. 1995;35:931-935.
33. Parkman R. Immunological reconstitution following bone marrow transplantation. In: Bone Marrow Transplantation. Boston, Mass: Blackwell Scientific; 1994:504-512.
34. Atkinson K. Reconstitution of hemopoietic and immune system after marrow transplantation. Bone Marrow Transplantation. 1990;5:209-226.
35. Friedberg RC. Transfusion therapy in the patient undergoing hematopoietic stem cell transplantation. Hematol Oncol Clin North Am. 1994;8:1105-1116.
36. Heddle NM, Soutar RL, O'Hoski PL. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol. 1995;91:1000-1005.